<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35836077</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1940-6029</ISSN><JournalIssue CitedMedium="Internet"><Volume>2525</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Methods in molecular biology (Clifton, N.J.)</Title><ISOAbbreviation>Methods Mol Biol</ISOAbbreviation></Journal><ArticleTitle>In Vivo Imaging of Oxidative and Hypoxic Stresses in Mice Model of Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>289</StartPage><EndPage>294</EndPage><MedlinePgn>289-294</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-0716-2473-9_22</ELocationID><Abstract><AbstractText>Oxidative and hypoxic stresses are associated with the degeneration of both motor neurons and skeletal muscles in amyotrophic lateral sclerosis (ALS). In vivo bioluminescent imaging is used to monitor cellular responses to oxidative and hypoxic stresses in living ALS model mice bearing G93A-human Cu/Zn superoxide dismutase (SOD1) longitudinally using the IVIS spectrum imaging system. Double transgenic mice bearing both Keap1-dependent oxidative stress detector No-48 (OKD48) and G93A-SOD1 are useful for in vivo imaging of oxidative stress in ALS. We developed a bioluminescence resonance energy transfer (BRET) probe that is regulated by HIF-1&#x3b1;-specific ubiquitin-proteasome system. G93A-SOD1 mice injected with the BRET probe are useful to investigate the spatiotemporal responses to hypoxic stress in ALS. In this chapter, we introduce a practical protocol of in vivo imaging of both oxidative and hypoxic stress in ALS model mice.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ohta</LastName><ForeName>Yasuyuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Neurology and Clinical Neuroscience, Department of Internal Medicine III, Yamagata University School of Medicine, Yamagata, Japan. yasuyuki@med.id.yamagata-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nomura</LastName><ForeName>Emi</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kizaka-Kondoh</LastName><ForeName>Shinae</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Center of Neurology and Psychiatry (NCNP), Kodaira city, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methods Mol Biol</MedlineTA><NlmUniqueID>9214969</NlmUniqueID><ISSNLinking>1064-3745</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072019">Kelch-Like ECH-Associated Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072019" MajorTopicYN="N">Kelch-Like ECH-Associated Protein 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051267" MajorTopicYN="N">NF-E2-Related Factor 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">Bioluminescence resonance energy transfer (BRET)</Keyword><Keyword MajorTopicYN="N">Hypoxia inducible factor-1 (HIF-1)</Keyword><Keyword MajorTopicYN="N">Hypoxic stress</Keyword><Keyword MajorTopicYN="N">In vivo imaging</Keyword><Keyword MajorTopicYN="N">Nuclear erythroid 2-related factor 2 (Nrf2)</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">Superoxide dismutase (SOD1)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35836077</ArticleId><ArticleId IdType="doi">10.1007/978-1-0716-2473-9_22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rosen DR (1993) Mutations in cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364(6435):362. https://doi.org/10.1038/364362c0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/364362c0</ArticleId><ArticleId IdType="pubmed">8332197</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki M, Ogasawara M, Matsubara Y, Narisawa K, Nakamura S, Itoyama Y, Abe K (1993) Mild ALS in Japan associated with novel SOD mutation. Nat Genet 5(4):323&#x2013;324. https://doi.org/10.1038/ng1293-323</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1293-323</ArticleId><ArticleId IdType="pubmed">8298637</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX et al (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264(5166):1772&#x2013;1775. https://doi.org/10.1126/science.8209258</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14(6):1105&#x2013;1116. https://doi.org/10.1016/0896-6273(95)90259-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, Lu Y, Gendron TF, Karydas A, Tran H, Yang D, Petrucelli L, Miller BL, Almeida S, Gao FB (2016) Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron 92(2):383&#x2013;391. https://doi.org/10.1016/j.neuron.2016.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId><ArticleId IdType="pmc">5111366</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D, Grubman A, Acevedo K, Yang S, Ke YD, Moujalled DM, Duncan C, Caragounis A, Perera ND, Turner BJ, Prudencio M, Petrucelli L, Blair I, Ittner LM, Crouch PJ, Liddell JR, White AR (2017) TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway. Hum Mol Genet 26(9):1732&#x2013;1746. https://doi.org/10.1093/hmg/ddx093</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx093</ArticleId><ArticleId IdType="pubmed">28334913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H, Nagano I, Murakami T, Shiote M, Shoji M, Abe K (2003) Sustained induction of survival p-AKT and p-ERK signals after transient hypoxia in mice spinal cord with G93A mutant human SOD1 protein. J Neurol Sci 215(1&#x2013;2):57&#x2013;62. https://doi.org/10.1016/s0022-510x(03)00186-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(03)00186-2</ArticleId><ArticleId IdType="pubmed">14568129</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SM, Kim H, Lee JS, Park KS, Jeon GS, Shon J, Ahn SW, Kim SH, Lee KM, Sung JJ, Lee KW (2013) Intermittent hypoxia can aggravate motor neuronal loss and cognitive dysfunction in ALS mice. PLoS One 8(11):e81808. https://doi.org/10.1371/journal.pone.0081808</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081808</ArticleId><ArticleId IdType="pubmed">24303073</ArticleId><ArticleId IdType="pmc">3841127</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitkanou S, Della Gatta PA, Russell AP (2016) Skeletal muscle satellite cells, mitochondria, and microRNAs: their involvement in the pathogenesis of ALS. Front Physiol 7:403. https://doi.org/10.3389/fphys.2016.00403</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2016.00403</ArticleId><ArticleId IdType="pubmed">27679581</ArticleId><ArticleId IdType="pmc">5020084</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler JP, Picchiarelli G, Dupuis L, Gonzalez De Aguilar JL (2016) The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathol 26(2):227&#x2013;236. https://doi.org/10.1111/bpa.12350</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12350</ArticleId><ArticleId IdType="pubmed">26780251</ArticleId><ArticleId IdType="pmc">8029271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta Y, Nomura E, Shang J, Feng T, Huang Y, Liu X, Shi X, Nakano Y, Hishikawa N, Sato K, Takemoto M, Yamashita T, Abe K (2019) Enhanced oxidative stress and the treatment by edaravone in mice model of amyotrophic lateral sclerosis. J Neurosci Res 97(5):607&#x2013;619. https://doi.org/10.1002/jnr.24368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24368</ArticleId><ArticleId IdType="pubmed">30565312</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura E, Ohta Y, Tadokoro K, Shang J, Feng T, Liu X, Shi X, Matsumoto N, Sasaki R, Tsunoda K, Sato K, Takemoto M, Hishikawa N, Yamashita T, Kuchimaru T, Kizaka-Kondoh S, Abe K (2019) Imaging hypoxic stress and the treatment of amyotrophic lateral sclerosis with dimethyloxalylglycine in a mice model. Neuroscience 415:31&#x2013;43. https://doi.org/10.1016/j.neuroscience.2019.06.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2019.06.025</ArticleId><ArticleId IdType="pubmed">31344397</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri S, Korner S, Kiaei M (2012) Nrf2/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS. Neurol Res Int 2012:878030. https://doi.org/10.1155/2012/878030</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/878030</ArticleId><ArticleId IdType="pubmed">23050144</ArticleId><ArticleId IdType="pmc">3461296</ArticleId></ArticleIdList></Reference><Reference><Citation>Mead RJ, Higginbottom A, Allen SP, Kirby J, Bennett E, Barber SC, Heath PR, Coluccia A, Patel N, Gardner I, Brancale A, Grierson AJ, Shaw PJ (2013) S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis. Free Radic Biol Med 61:438&#x2013;452. https://doi.org/10.1016/j.freeradbiomed.2013.04.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.04.018</ArticleId><ArticleId IdType="pubmed">23608463</ArticleId><ArticleId IdType="pmc">3684770</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikawa D, Akai R, Tokuda M, Iwawaki T (2012) A transgenic mouse model for monitoring oxidative stress. Sci Rep 2:229. https://doi.org/10.1038/srep00229</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00229</ArticleId><ArticleId IdType="pubmed">22355743</ArticleId><ArticleId IdType="pmc">3261443</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang LE, Arany Z, Livingston DM, Bunn HF (1996) Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 271(50):32253&#x2013;32259. https://doi.org/10.1074/jbc.271.50.32253</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.50.32253</ArticleId><ArticleId IdType="pubmed">8943284</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada H, Hiraoka M, Kizaka-Kondoh S (2002) Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells. Cancer Res 62(7):2013&#x2013;2018</Citation><ArticleIdList><ArticleId IdType="pubmed">11929818</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O&#x2019;Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107(1):43&#x2013;54. https://doi.org/10.1016/s0092-8674(01)00507-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(01)00507-4</ArticleId><ArticleId IdType="pubmed">11595184</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Mino K, Akimoto H, Kawabata M, Nakamura K, Ozaki M, Ohmiya Y (2009) In vivo far-red luminescence imaging of a biomarker based on BRET from Cypridina bioluminescence to an organic dye. Proc Natl Acad Sci U S A 106(37):15599&#x2013;15603. https://doi.org/10.1073/pnas.0908594106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908594106</ArticleId><ArticleId IdType="pubmed">19805215</ArticleId><ArticleId IdType="pmc">2739870</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong L, Shuhendler AJ, Rao J (2012) Self-luminescing BRET-FRET near-infrared dots for in vivo lymph-node mapping and tumour imaging. Nat Commun 3:1193. https://doi.org/10.1038/ncomms2197</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2197</ArticleId><ArticleId IdType="pubmed">23149738</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuchimaru T, Suka T, Hirota K, Kadonosono T, Kizaka-Kondoh S (2016) A novel injectable BRET-based in vivo imaging probe for detecting the activity of hypoxia-inducible factor regulated by the ubiquitin-proteasome system. Sci Rep 6:34311. https://doi.org/10.1038/srep34311</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep34311</ArticleId><ArticleId IdType="pubmed">27698477</ArticleId><ArticleId IdType="pmc">5048432</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano Y, Yamashita T, Li Q, Sato K, Ohta Y, Morihara R, Hishikawa N, Abe K (2017) Time-dependent change of in vivo optical imaging of oxidative stress in a mouse stroke model. J Neurosci Res 95(10):2030&#x2013;2039. https://doi.org/10.1002/jnr.24047</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24047</ArticleId><ArticleId IdType="pubmed">28276088</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X, Ohta Y, Nakano Y, Liu X, Tadokoro K, Feng T, Nomura E, Tsunoda K, Sasaki R, Matsumoto N, Osakada Y, Bian Y, Bian Z, Omote Y, Takemoto M, Hishikawa N, Yamashita T, Abe K (2021) Neuroprotective effect of CuATSM in mice stroke model by ameliorating oxidative stress. Neurosci Res 166:55&#x2013;61. https://doi.org/10.1016/j.neures.2020.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2020.05.009</ArticleId><ArticleId IdType="pubmed">32461139</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta Y, Nagai M, Miyazaki K, Tanaka N, Kawai H, Mimoto T, Morimoto N, Kurata T, Ikeda Y, Matsuura T, Abe K (2011) Neuroprotective and angiogenic effects of bone marrow transplantation combined with granulocyte colony-stimulating factor in a mouse model of amyotrophic lateral sclerosis. Cell Med 2(2):69&#x2013;83. https://doi.org/10.3727/215517910X582779</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/215517910X582779</ArticleId><ArticleId IdType="pubmed">26998403</ArticleId><ArticleId IdType="pmc">4789328</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>